FY2026 EPS Estimates for Journey Medical Cut by Roth Capital
Journey Medical Co. (NASDAQ:DERM – Free Report) – Equities researchers at Roth Capital decreased their FY2026 earnings per share (EPS) estimates for Journey Medical in a research note issued to investors on Thursday, May 15th. Roth Capital analyst J. Wittes now forecasts that the company will earn $2.02 per share for the year, down from […]
Journey Medical Co. (NASDAQ:DERM – Free Report) – Equities researchers at Roth Capital decreased their FY2026 earnings per share (EPS) estimates for Journey Medical in a research note issued to investors on Thursday, May 15th. Roth Capital analyst J. Wittes now forecasts that the company will earn $2.02 per share for the year, down from […]
